Video | 15 February 2020 Big pharma is double dipping 1 min RESEARCH AND DEVELOPMENT Medicines made with help from OUR taxes should be accessible to EVERYONE who needs them. SHARE this video and tell our leaders to stand up to Big Pharma’s double-dip profiteering. Share this message! Tell your leaders: We won’t pay twice for medicines any more. Share on Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicLetterNewsletterOpinion articlePress releaseReportResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Photograph by Valérie Batselaere Statement Statement | 23 January 2025 Pandemic preparedness Antimicrobial resistance Intellectual property and trade Research and development Tropical & neglected diseases Vaccines MSF statement on US decision to withdraw from WHO Photograph by Alexandra Sadokova Press release Press release | 25 April 2024 Transparency Research and development Tuberculosis In precedent-setting move towards drug-development cost transparency, MSF reveals cost of its landmark TB clinical trial: €34 million 6 min Technical brief | 25 April 2024 Transparency Research and development Transparency CORE: Clinical Trial Cost Reporting Toolkit Technical brief | 17 July 2023 Pandemic preparedness Intellectual property and trade Research and development MSF Position Paper: Ensuring Timely and Equitable Access to Medical Products in Global Public Health Emergencies Technical brief | 22 May 2023 Research and development Roundtable: Disclosing Clinical Trial Costs – Why and How Should It Be Done? Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min Statement Statement | 17 November 2022 Research and development MSF publishes first Clinical Trial Transparency Policy 5 min Load More
Photograph by Valérie Batselaere Statement Statement | 23 January 2025 Pandemic preparedness Antimicrobial resistance Intellectual property and trade Research and development Tropical & neglected diseases Vaccines MSF statement on US decision to withdraw from WHO
Photograph by Alexandra Sadokova Press release Press release | 25 April 2024 Transparency Research and development Tuberculosis In precedent-setting move towards drug-development cost transparency, MSF reveals cost of its landmark TB clinical trial: €34 million 6 min
Technical brief | 25 April 2024 Transparency Research and development Transparency CORE: Clinical Trial Cost Reporting Toolkit
Technical brief | 17 July 2023 Pandemic preparedness Intellectual property and trade Research and development MSF Position Paper: Ensuring Timely and Equitable Access to Medical Products in Global Public Health Emergencies
Technical brief | 22 May 2023 Research and development Roundtable: Disclosing Clinical Trial Costs – Why and How Should It Be Done?
Statement | 01 February 2023 Research and development MSF Statement on EB152/13 - Strengthening clinical trials to provide high-quality evidence on health interventions and to improve research quality and coordination 1 min
Statement | 01 February 2023 Research and development MSF Statement on EB152/7 - Substandard and falsified medical products 1 min
Statement Statement | 17 November 2022 Research and development MSF publishes first Clinical Trial Transparency Policy 5 min